Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larry J Anderson

Showing results (31-40 of 187) with videos related to

Pageof 19
Sort By:
The Pediatric Infectious Disease Journal|October 11, 2003
Substantial variability in community respiratory syncytial virus season timingJames A Mullins, Ashley C Lamonte, Joseph S Bresee, et al.
The Pediatric Infectious Disease Journal|August 6, 2011
Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997-2006Lauren J Stockman, Aaron T Curns, Larry J Anderson, et al.
MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports|March 30, 2004
Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory CommitteeOfelia C Tablan, Larry J Anderson, Richard Besser, et al.
Vaccine|June 12, 2003
CD40 ligand (CD154) improves the durability of respiratory syncytial virus DNA vaccination in BALB/c miceJennifer L Harcourt, Michael P Brown, Larry J Anderson, et al.
The Pediatric Infectious Disease Journal|August 6, 2010
Respiratory syncytial virus and Staphylococcus aureus coinfection in children hospitalized with pneumoniaLauren J Stockman, Carrie Reed, Alexander J Kallen, et al.
Journal of Virology|August 28, 2003
Enhanced disease and pulmonary eosinophilia associated with formalin-inactivated respiratory syncytial virus vaccination are linked to G glycoprotein CX3C-CX3CR1 interaction and expression of substance PLia M Haynes, Les P Jones, Albert Barskey, et al.
The Journal of General Virology|March 3, 2004
Sequence polymorphism of the predicted human metapneumovirus G glycoproteinTeresa C T Peret, Yacine Abed, Larry J Anderson, et al.
Journal of Clinical Microbiology|June 27, 2008
Sensitive and broadly reactive reverse transcription-PCR assays to detect novel paramyxovirusesSuxiang Tong, Shur-Wern Wang Chern, Yan Li, et al.
Plos One|January 10, 2013
Combination therapy using monoclonal antibodies against respiratory syncytial virus (RSV) G glycoprotein protects from RSV disease in BALB/c miceHayat Caidi, Jennifer L Harcourt, Ralph A Tripp, et al.
Plos One|June 27, 2013
Response to rhinovirus infection by human airway epithelial cells and peripheral blood mononuclear cells in an in vitro two-chamber tissue culture systemDevi Rajan, Kelsey A Gaston, Courtney E McCracken, et al.
Pageof 19

Showing results (31-40 of 187) with videos related to

Sort By:
Pageof 19
The Pediatric Infectious Disease Journal|October 11, 2003
Substantial variability in community respiratory syncytial virus season timingJames A Mullins, Ashley C Lamonte, Joseph S Bresee, et al.
The Pediatric Infectious Disease Journal|August 6, 2011
Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997-2006Lauren J Stockman, Aaron T Curns, Larry J Anderson, et al.
MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports|March 30, 2004
Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory CommitteeOfelia C Tablan, Larry J Anderson, Richard Besser, et al.
Vaccine|June 12, 2003
CD40 ligand (CD154) improves the durability of respiratory syncytial virus DNA vaccination in BALB/c miceJennifer L Harcourt, Michael P Brown, Larry J Anderson, et al.
The Pediatric Infectious Disease Journal|August 6, 2010
Respiratory syncytial virus and Staphylococcus aureus coinfection in children hospitalized with pneumoniaLauren J Stockman, Carrie Reed, Alexander J Kallen, et al.
Journal of Virology|August 28, 2003
Enhanced disease and pulmonary eosinophilia associated with formalin-inactivated respiratory syncytial virus vaccination are linked to G glycoprotein CX3C-CX3CR1 interaction and expression of substance PLia M Haynes, Les P Jones, Albert Barskey, et al.
The Journal of General Virology|March 3, 2004
Sequence polymorphism of the predicted human metapneumovirus G glycoproteinTeresa C T Peret, Yacine Abed, Larry J Anderson, et al.
Journal of Clinical Microbiology|June 27, 2008
Sensitive and broadly reactive reverse transcription-PCR assays to detect novel paramyxovirusesSuxiang Tong, Shur-Wern Wang Chern, Yan Li, et al.
Plos One|January 10, 2013
Combination therapy using monoclonal antibodies against respiratory syncytial virus (RSV) G glycoprotein protects from RSV disease in BALB/c miceHayat Caidi, Jennifer L Harcourt, Ralph A Tripp, et al.
Plos One|June 27, 2013
Response to rhinovirus infection by human airway epithelial cells and peripheral blood mononuclear cells in an in vitro two-chamber tissue culture systemDevi Rajan, Kelsey A Gaston, Courtney E McCracken, et al.
Pageof 19